Homatropine methylbromide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for homatropine methylbromide and what is the scope of patent protection?
Homatropine methylbromide
is the generic ingredient in eight branded drugs marketed by Mission Pharma, Genus, Abhai Llc, Actavis Mid Atlantic, Apozeal Pharms, Ivax Sub Teva Pharms, Nostrum Labs Inc, Novel Labs Inc, Padagis Us, Pai Holdings Pharm, Wockhardt Bio Ag, Halsey, Actavis Elizabeth, Avanthi Inc, and King Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for homatropine methylbromide.
Summary for homatropine methylbromide
US Patents: | 0 |
Tradenames: | 8 |
Applicants: | 15 |
NDAs: | 18 |
Drug Master File Entries: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
DailyMed Link: | homatropine methylbromide at DailyMed |
US Patents and Regulatory Information for homatropine methylbromide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Mid Atlantic | HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE | homatropine methylbromide; hydrocodone bitartrate | SYRUP;ORAL | 088017-001 | Jul 5, 1983 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Mission Pharma | HOMAPIN-5 | homatropine methylbromide | TABLET;ORAL | 086309-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mission Pharma | HOMAPIN-10 | homatropine methylbromide | TABLET;ORAL | 086308-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |